Skip to content

Comparison of PENG Block and FICB in Hip Fracture Patients

Comparison of Analgesic Effect of Pericapsular Nerve Group Block and Suprainguinal Fascia Iliaca Compartment Block on Dynamic Pain in Patients Undergoing Hip Fracture Surgery: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04677348
Enrollment
80
Registered
2020-12-21
Start date
2021-01-21
Completion date
2022-02-11
Last updated
2022-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fractures, Regional Anesthesia

Keywords

pericapsular nerve group block, fascia iliaca compartment block, hip fracture, regional anesthesia, dynamic pain

Brief summary

Fascia iliaca compartment block (FICB) has been considered the block of choice for patients with hip fracture. However, pericapsular nerve group (PENG) block, one of the relatively newly-developed blocks, could be also used for analgesia in patients with hip fracture. Since PENG block could block the accessory obturator nerve, PENG block might have greater analgesic effects compared to FICB theoretically. However, the comparison of these two blocks in patients with hip fracture has not performed in clinical setting. Thus, we aimed to compare the analgesic effect of PENG block and FICB.

Interventions

PROCEDUREPericapsular nerve group (PENG) block

ultrasound-guided PENG block with 0.3% ropivacaine 20cc

ultrasound-guided suprainguinal FICB with 0.3% ropivacaine 30cc

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ASA PS 1-4 * age: ≥19 * baseline pain score (associated with hip fracture): ≥4

Exclusion criteria

* patients who do not agree to participate in this study * patients with uncontrolled hypertension, hyperthyroidism, severe dementia * allergic to ropivacaine * contraindicated to spinal anesthesia due to coagulopathy, severe aortic stenosis/mitral stenosis, or active infection on lumbar region * patients who are considered ineligible with any other reason by investigators

Design outcomes

Primary

MeasureTime frameDescription
Efficacy of each block (Pain score)before surgeryWe will assess the dynamic pain (pain during a movement) using NRS before and 20-30min after applying the assigned block. Then, we will calculate the change of NRS at the two time-points. NRS: Numerical rating scale (0, no pain; 10, the worst pain imaginable)

Secondary

MeasureTime frameDescription
change of heart ratebefore surgeryWe will evaluate the heart rate before and 20-30 min after applying the assigned block. Then, we will calculate the change of heart rate at the two time-points.
change of blood pressure (systolic, diastolic, mean blood pressure)before surgeryWe will evaluate the blood pressure before and 20-30min after applying the assigned block. Then, we will calculate the change of blood pressure at the two time-points.
postoperative pain scorepostoperative 6, 24, 48hoursresting and dynamic pain using NRS at postoperative 6, 24, 48hours NRS: Numerical rating scale (0, no pain; 10, the worst pain imaginable)
postoperative opioid consumptionpostoperative 24, 48hoursmorphine-equivalent dose
postoperative motor functionpostoperative 6, 24, 48hoursmotor function of quadriceps femoris grade5: normal power grade4: movement possible against some resistance grade3: movement against gravity but not resistance grade2: movement possible if gravity eliminated grade1: flicker of contraction possible grade0: complete paralysis

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026